Related Experiment Video
Updated: Apr 30, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report
Pei-Hung Chang1, Mei-Ti Wang2, Yi-Hua Chen2
1Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 20445, Taiwan, R.O.C.
Abstract:
Chemotherapeutic agents can result in extravasation, which is considered to be a serious complication. The increasing number of exposures to different cytotoxic agents experienced by each patient may enhance the prevalence of this complication. Docetaxel is widely used in the treatment of numerous solid tumors. Thus, the current report presents the case of a breast cancer patient who developed a significantly delayed skin reaction one day after docetaxel extravasation, a rare skin manifestation, and relapsed one week subsequently. This unusual clinical presentation is an indicator that practitioners are required to carefully monitor the patient for further cutaneous reactions in the weeks following extravasation to observe any additional adverse reactions.
Related Concept Videos
Cytotoxic Edema: Pathophysiology
Drug Toxicity: Allergic Reactions
Clinical Applications of Epidermal Stem Cells
Healing II: Complications

